| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.0056 | 1 |